ARCHIVES

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987

Two Private Cancer Information Services Are Up and Running

May 13, 1988

GM Foundation Awards Prizes

June 13, 2003

Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview)

May 16, 2003

New Policy on Minor Changes in Trials Requires Halt in Patient Enrollment.

April 25, 2008